In the history of American bureaucracy, few ideas have carried the sting of satire and the force of reform as powerfully as Steve Davis’s $1 credit card limit. It is a solution so blunt, so absurd on its face, that only a government so accustomed to inertia could have missed it for decades. And yet, here it is, at the center of a sprawling audit by the Department of Government Efficiency, or DOGE, that has, in just seven weeks, eliminated or disabled 470,000 federal charge cards across thirty agencies. The origin of this initiative reveals more than cleverness or thrift. It reflects a new attitude, one that insists the machinery of government need not be calcified. The federal workforce, long derided as passive and obstructionist, is now being challenged to solve problems, not explain why they cannot be solved. This, more than any tally of dollars saved, may be DOGE’s greatest achievement.
When Elon Musk assumed control of DOGE under President Trump’s second administration, he brought with him an instinct for disruption. But disruption, as many reformers have learned, is often easier said than done. Take federal credit cards. There were, as of early 2025, roughly 4.6 million active accounts across the federal government, while the civilian workforce comprised fewer than 3 million employees. Even the most charitable reading suggests gross redundancy. More cynical observers see potential for abuse. DOGE asked the obvious question: why so many cards? The initial impulse was to cancel them outright. But as is often the case in government, legality is not aligned with simplicity.
Enter Steve Davis. Known for his austere management style and history with Musk-led enterprises, Davis encountered legal counsel who informed him that mass cancellation would breach existing contracts, violate administrative rules, and risk judicial entanglement. Most would stop there. But Davis, adhering to Musk’s ethos of first-principles thinking, chose another route. If the cards could not be canceled, could they be rendered functionally useless? Yes. Set their limits to $1.
This workaround achieved in days what years of audits and Inspector General warnings had not. The cards remained technically active, sidestepping the legal landmines of cancellation, but were practically neutered. The act was swift, surgical, and reversible. It allowed agencies to petition for exemptions in cases of genuine operational need, but forced every cardholder and department head to justify the existence of each card. Waste thrives in opacity. The $1 cap turned on the lights.
Naturally, the immediate reaction inside many agencies was panic. At the National Park Service, staff could not process trash removal contracts. At the FDA, scientific research paused as laboratories found themselves unable to order reagents. At the Department of Defense, travel for civilian personnel ground to a halt. Critics likened it to a shutdown, albeit without furloughs. Others, more charitable, described it as a stress test. And indeed, that is precisely what it was: a large-scale audit conducted not by paper trails and desk reviews, but by rendering all purchases impossible and observing who protested, why, and with what justification.
This approach reflects a deeper philosophical question. What is government for? Is it a perpetuator of routine, or a servant of necessity? The DOGE initiative, in its credit card audit, insisted that nothing in government spending ought to be assumed sacred or automatic. Every purchase, every expense, must be rooted in mission-critical need. And for that to happen, a culture shift must occur, not merely in policy, but in mindset. The federal worker must no longer be an apologist for the status quo, but an agent of reform.
Remarkably, this message has found traction. Inside the agencies affected by the freeze, DOGE has reported a surge in what one official described as “constructive dissent.” Civil servants who once reflexively recited reasons for inaction are now offering alternative mechanisms, revised workflows, and digital solutions. One employee at the Department of Agriculture proposed consolidating regional office supply chains after realizing that over a dozen separate cardholders were purchasing duplicative items within the same week. A NOAA field team discovered it could pool resources for bulk procurement, saving money and reducing redundancy. These are not acts of whistleblowing or radical restructuring. They are small, localized acts of efficiency, and they matter.
Critics argue that these are marginal gains and that the real drivers of federal bloat lie elsewhere: entitlement spending, defense procurement, or healthcare subsidies. And they are not wrong. But they miss the point. DOGE’s $1 limit was not about accounting minutiae, it was about psychology. In a system where inertia reigns, a symbolic shock is often the necessary prelude to substantive reform. The act of asking why, why this card, why this purchase, why this employee, forces a reappraisal that scales. Culture, not just cost, was the target.
There is a danger here, of course. Symbolism can become performance, and austerity can become vanity. If agencies are deprived of necessary tools for the sake of headlines, then reform becomes sabotage. This is why the $1 policy included an appeals process, a mechanism for restoring functionality where needed. In a philosophical sense, this is the principle of proportionality applied to public finance: restrictions should be commensurate with the likelihood of abuse, and reversible upon demonstration of legitimate need.
DOGE’s broader audit, still underway, has now expanded to cover nearly thirty agencies. It is not simply cutting cards. It is classifying them, comparing issuance practices, flagging statistical anomalies, and building a federal dashboard of real-time usage. This is not glamorous work. There are no ribbon-cuttings, no legacy-defining achievements. But it is the marrow of good governance. As Aristotle noted, excellence is not an act, but a habit. The DOGE team has adopted a habit of scrutiny. And that habit, when instilled in the civil service, is a kind of virtue.
Here we arrive at the most profound implication. What if the federal workforce is not inherently wasteful or cynical, but simply trapped in a system that rewards compliance over creativity? What if, when given both the mandate and the moral permission to think, civil servants become problem solvers? The $1 limit policy is, in this light, less a budgetary tool than a pedagogical one. It teaches. It asks employees to imagine how their department might function if every dollar mattered, and to act accordingly.
In a bureaucratic culture where the phrase “we can’t do that” serves as both shield and apology, DOGE has introduced a new mantra: try. Try to find the workaround. Try to reimagine procurement. Try to do more with less. This shift may not register on a spreadsheet. It may not win an election. But it rehumanizes the federal workforce. It treats them not as drones executing policy, but as intelligent actors capable of judgment, reform, and even invention.
The future of DOGE will no doubt face resistance. Unions, entrenched bureaucrats, and political opponents will argue it oversteps or misunderstands the delicate machinery of governance. Some of that criticism will be valid. But what cannot be denied is that DOGE has already achieved something rare: it has made federal workers think differently. It has shown that even the most byzantine of systems contains levers for change—if one is willing to pull them.
The $1 card limit is not a policy; it is a parable. It tells us that in the face of complexity, simplicity is a virtue. That in the face of inertia, audacity has a place. And that in the face of sprawling bureaucracies, sometimes the best way to fix the machine is to unplug it and see who calls to complain. That is when the real work begins.
Sponsored by the John Milton Freedom Foundation, a nonprofit dedicated to helping independent journalists overcome formidable challenges in today’s media landscape and bring crucial stories to you.
READ NEXT: Federal Judge Blocks Hugely Popular Trump-Backed Reform
MAHA Year One: How Trump & RFK Jr. Are Rebuilding American Health
For decades, Americans were told a story about their health that no longer matched reality. We were assured that food was safe, that regulators were vigilant, that medical advice was insulated from politics and profit, and that rising chronic disease was an unfortunate but unavoidable byproduct of modern life. Meanwhile, the health of the nation deteriorated in plain sight. Obesity climbed year after year. Childhood chronic disease became common rather than exceptional. Autism rates surged. Cancer diagnoses among children rose. By the time President Trump returned to office, 76.4% of Americans were living with at least one chronic disease. Eight out of 10 children could not qualify for military service. What should have been treated as a civilizational emergency was instead normalized, until that long-running failure of honesty and accountability culminated during the COVID-19 pandemic, when public health leaders abandoned transparency, misled the public, and, under Dr. Fauci’s direction, shattered trust in medical professionals and the institutions meant to serve them.
The collapse of trust that followed COVID did not occur in a vacuum. It was the culmination of years of regulatory capture, scientific arrogance, and a public health establishment that confused authority with truth. Americans were ordered, not persuaded. Dissent was pathologized. Data was selectively presented. Vaccine policy was enforced through mandate rather than transparency. Dr. Fauci became the symbol of an anti-science regime that claimed infallibility while revising its claims in real time. When institutions insist on obedience while refusing accountability, trust does not merely erode; it implodes.
It is against this backdrop that the Make America Healthy Again initiative must be understood. MAHA is not a branding exercise or a partisan slogan. It is a course correction. President Trump’s decision to place Robert F. Kennedy Jr. at the helm of HHS was not an appeal to nostalgia or name recognition. It was an explicit rejection of the managerial consensus that presided over the chronic disease explosion. The mandate was simple and radical: identify root causes, dismantle regulatory capture, and tell the truth even when it disrupts powerful interests.
Skeptics ask whether one year can matter. The answer depends on what one expects a first year to do. MAHA was never going to reverse decades of metabolic, environmental, and institutional decay overnight. Its purpose was to reorient the system, establish credibility, and force long-delayed questions back into the open. By that standard, the first year has been historic.
Start with the scope of institutional change. President Trump signed an executive order establishing the MAHA Commission, chaired by Secretary Kennedy, with a singular focus on chronic disease. For the first time in generations, chronic illness was treated not as an actuarial inevitability but as a policy failure demanding investigation. This alone marked a break with orthodoxy. Under previous administrations, chronic disease spending rose to $1.3T annually while prevention remained an afterthought. When Kennedy notes that the federal government once spent essentially nothing on chronic disease, he is not making a rhetorical point. He is diagnosing a structural blind spot.
The results are already visible. Thirty-seven states have enacted legislation advancing MAHA-aligned reforms. Nearly 100 MAHA-related bills have passed nationwide. Eighteen states secured SNAP waivers to restrict taxpayer-funded junk food purchases that directly fuel obesity and diabetes. These are not symbolic victories. They are structural incentives aligned with public health rather than industry convenience.
Food policy has been the most visible arena of reform, and for good reason. The American diet did not become toxic by accident. It was engineered through regulatory loopholes that allowed synthetic additives to enter the food supply under the GRAS standard with minimal oversight. MAHA moved quickly to overhaul this system. Agreements now cover roughly 40% of the food industry, committing to remove petroleum-based synthetic dyes. The dairy industry has pledged to eliminate artificial dyes from ice cream by 2028. These changes matter because they reset norms. Once voluntary reform becomes expected, resistance collapses.
The same logic applies to infant health. Operation Stork Speed was launched to expand access to safe and nutritious infant formula while removing heavy metals that had no business entering baby food in the first place. For parents who watched institutions minimize legitimate safety concerns during COVID, this shift toward precaution and transparency has been decisive in rebuilding trust.
Critics often ask whether MAHA is anti-science. The premise is backward. MAHA is anti-dogma. It insists that science earns authority through openness, replication, and humility. This is why vaccine policy has been reframed around informed consent and gold standard trials rather than mandates. Honesty about uncertainty is not weakness. It is the precondition of credibility. Public trust returns when institutions stop pretending to be omniscient.
This emphasis on trust extends beyond food and vaccines. HHS issued guidance restoring biological truth, recognizing that there are two sexes, male and female. This was not culture war theater. Medicine depends on biological reality. When institutions deny observable facts for ideological reasons, patients notice. Restoring clarity restores confidence.
MAHA’s critics also underestimate the importance of state-level experimentation. Utah’s decision to ban added fluoride in public drinking water did not impose a national mandate. It reopened a conversation that had been closed by bureaucratic inertia. Communities are once again allowed to weigh risks and benefits rather than defer to outdated consensus.
Health care delivery itself has not been ignored. Prior authorization has long functioned as a hidden tax on patients and physicians, delaying care while enriching intermediaries. Secretary Kennedy and CMS Administrator Oz secured industry commitments to streamline this process across health plans. Less paperwork means faster treatment and lower burnout. These are the reforms patients feel immediately.
Drug pricing has followed the same philosophy. President Trump’s most favored nation order is being rapidly implemented to align U.S. prescription drug prices with those paid abroad. This is not price control masquerading as populism. It is a refusal to subsidize global markets at the expense of American patients. Lower prices are a public health intervention.
Physical health has returned to the cultural mainstream as well. The Pete and Bobby Challenge, launched by Secretary Kennedy alongside Defense Secretary Hegseth, did something that countless white papers failed to do. It made fitness visible again. A nation where most children cannot meet basic physical standards is not merely unhealthy. It is vulnerable.
The MAHA Commission’s release of the Make Our Children Healthy Again strategy, outlining more than 120 initiatives, signaled that childhood chronic disease is no longer being treated as a mystery or a taboo. New data linking rising thyroid and kidney cancers among children demands answers. Autism rates demand answers. MAHA has made clear that asking these questions is not forbidden. It is required.
Perhaps the most underestimated achievement of the first year is cultural rather than regulatory. Trust is returning because institutions are speaking plainly. The public understands that special interests once thrived behind closed doors. They know they were sold better cigarettes and sugar smacks with a health halo. What they demanded in 2024 was not perfection. It was honesty.
President Trump and Secretary Kennedy have delivered the first credible attempt in decades to dismantle the alliance between bureaucratic power and corporate profit that hollowed out public health. The appointments at NIH, FDA, and CMS reflect this shift. These are not partisan enforcers. They are reformers tasked with ending capture and restoring the mission.
No serious observer should claim that the work is finished. Chronic disease did not emerge in one year, and it will not be eliminated in one term. But trajectories matter. Incentives matter. Trust matters most of all. After years in which Americans were told to comply and not question, MAHA has reopened the social contract between the public and medicine.
Public health cannot function without consent. Consent requires trust. Trust requires truth. That is the chain MAHA is rebuilding. It is why the first year matters. Not because every problem has been solved, but because the system has finally been pointed in the right direction.
If you enjoy my work, please subscribe: https://x.com/amuse.
Sponsored by the John Milton Freedom Foundation, a nonprofit dedicated to helping independent journalists overcome formidable challenges in today’s media landscape and bring crucial stories to you.
Sponsored
Arizona is at risk — and Turning Point needs you NOW. Your donation funds ballot chasers and wins critical state races. Donate TODAY to help save America — one state at a time.